Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Antimicrobial resistance in Streptococcus pneumoniae isolates from invasive pneumococcal infections in Iran.

Rahbar M, Dolatyar Dehkharghani A, Zahraei SM, Mardani M, Mohammadzadeh M.

J Glob Antimicrob Resist. 2019 Mar;16:260-261. doi: 10.1016/j.jgar.2019.02.009. Epub 2019 Feb 20. No abstract available.

PMID:
30797089
2.

Estimation of measles risk using the World Health Organization Measles Programmatic Risk Assessment Tool, Iran.

Mohammadbeigi A, Zahraei SM, Asgarian A, Afrashteh S, Mohammadsalehi N, Khazaei S, Ansari H.

Heliyon. 2018 Nov 1;4(11):e00886. doi: 10.1016/j.heliyon.2018.e00886. eCollection 2018 Nov.

3.

Monitoring of Surveillance Quality Indicators of Measles in Iranian Districts: Analysis of Measles Surveillance System 2014-2016.

Zahraei SM, Mohammadbeigi A, Mohammadsalehi N, Sabouri A, Afrashteh S, Arsang Jang S, Ansari H, Khazaei S.

J Res Health Sci. 2018 Jun 30;18(3):e00418.

PMID:
30270213
4.

Enteroviruses and Adenoviruses in stool specimens of paralytic children- can they be the cause of paralysis?

Yousefi M, Nejati A, Zahraei SM, Mahmoudi S, Parhizgari N, Farsani SMJ, Mahmoodi M, Nategh R, Shahmahmoodi S.

Iran J Microbiol. 2018 Jun;10(3):194-201.

5.

Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran.

Sadeghpour Heravi F, Nikbin VS, Nakhost Lotfi M, Badiri P, Jannesar Ahmadi N, Zahraei SM, Shahcheraghi F.

Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1893-1900. doi: 10.1007/s10096-018-3323-6. Epub 2018 Aug 9.

PMID:
30094521
6.

Sero-epidemiological evaluation of rubella immunity among pre-marriage women in Iran.

Zahraei SM, Azad TM, Sabouri A, Khazaei S, Karami M.

Hum Vaccin Immunother. 2018 Jul 26. doi: 10.1080/21645515.2018.1504527. [Epub ahead of print]

PMID:
30047822
7.

Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran.

Yaghoubi M, Nojomi M, Vaezi A, Erfani V, Mahmoudi S, Ezoji K, Zahraei SM, Chaudhri I, Moradi-Lakeh M.

Value Health Reg Issues. 2018 May;15:112-119. doi: 10.1016/j.vhri.2018.03.001. Epub 2018 Apr 24.

PMID:
29698864
8.

Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran.

Izadi S, Zahraei SM, Mokhtari-Azad T.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1412-1416. doi: 10.1080/21645515.2018.1436920. Epub 2018 Feb 26.

9.

Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.

Izadi S, Zahraei SM, Salehi M, Mohammadi M, Tabatabaei SM, Mokhtari-Azad T.

Vaccine. 2018 Jan 29;36(5):631-636. doi: 10.1016/j.vaccine.2017.12.048. Epub 2017 Dec 27.

PMID:
29289382
10.

Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran.

Karami M, Ameri P, Bathaei J, Berangi Z, Pashaei T, Zahiri A, Zahraei SM, Erfani H, Ponnet K.

BMC Immunol. 2017 Oct 5;18(1):45. doi: 10.1186/s12865-017-0228-6. No abstract available.

11.

Documentation of Measles Elimination in Iran: Evidences from 2012 to 2014.

Karami M, Zahraei SM, Sabouri A, Soltanshahi R, Biderafsh A, Piri N, Lee JK.

J Res Health Sci. 2017 Aug 5;17(3):e00387.

12.

Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran.

Karami M, Ameri P, Bathaei J, Berangi Z, Pashaei T, Zahiri A, Zahraei SM, Erfani H, Ponnet K.

BMC Immunol. 2017 Aug 23;18(1):42. doi: 10.1186/s12865-017-0226-8. Erratum in: BMC Immunol. 2017 Oct 5;18(1):45.

13.

Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.

Teimouri F, Kebriaeezadeh A, Zahraei SM, Gheiratian M, Nikfar S.

Daru. 2017 Jan 14;25(1):1. doi: 10.1186/s40199-017-0166-0.

14.

Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.

Shaghaghi M, Shahmahmoodi S, Abolhassani H, Soleyman-Jahi S, Parvaneh L, Mahmoudi S, Chavoshzadeh Z, Yazdani R, Zahraei SM, Ebrahimi M, Eslamian MH, Tabatabaie H, Yousefi M, Kandelousi YM, Oujaghlou A, Rezaei N, Aghamohammadi A.

Emerg Infect Dis. 2016 Oct;22(10):1712-9. doi: 10.3201/eid2210.151071.

15.

Development and Optimization of a Homemade ELISA Kit for Detection of Antibodies Against Haemophilus influenzae Type b.

Mousavi SF, Fatemi S, Siadat SD, Zahraei SM, Nikanpour E, Malekan MA, Khabiri AR, Janani AR.

Jundishapur J Microbiol. 2016 Feb 17;9(5):e30629. doi: 10.5812/jjm.30629. eCollection 2016 May.

16.

Factors affecting the seroconversion rate of 12-month-old babies after the first injection of measles vaccine in the southeast of Iran.

Zahraei SM, Izadi S, Mokhtari-Azad T.

Hum Vaccin Immunother. 2016 Dec;12(12):3118-3124. doi: 10.1080/21645515.2016.1214346. Epub 2016 Jul 26.

17.

Comparing Seasonal Pattern of Laboratory Confirmed Cases of Pertussis with Clinically Suspected Cases.

Ghorbani GR, Zahraei SM, Moosazadeh M, Afshari M, Doosti F.

Osong Public Health Res Perspect. 2016 Apr;7(2):131-7. doi: 10.1016/j.phrp.2016.02.004. Epub 2016 Feb 23.

18.

Survival Analysis for Predictive Factors of Delay Vaccination in Iranian Children.

Mohammadbeigi A, Mokhtari M, Zahraei SM, Eshrati B, Rejali M.

Int J Prev Med. 2015 Dec 1;6:119. doi: 10.4103/2008-7802.170868. eCollection 2015.

20.

Risk Factors of Delay Proportional Probability in Diphtheria-tetanus-pertussis Vaccination of Iranian Children; Life Table Approach Analysis.

Mokhtari M, Rezaeimanesh M, Mohammadbeigi A, Zahraei SM, Mohammadsalehi N, Ansari H.

J Glob Infect Dis. 2015 Oct-Dec;7(4):165-9. doi: 10.4103/0974-777X.170503.

21.

The cost effectiveness of rotavirus vaccination in Iran.

Mousavi Jarrahi Y, Zahraei SM, Sadigh N, Esmaeelpoor Langeroudy K, Khodadost M, Ranjbaran M, Sanjari Moghaddam A, Besharat M, Mosavi Jarrahi A.

Hum Vaccin Immunother. 2016 Mar 3;12(3):794-800. doi: 10.1080/21645515.2015.1087626.

22.

Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.

Javanbakht M, Moradi-Lakeh M, Yaghoubi M, Esteghamati A, Mansour Ghanaie R, Mahmoudi S, Shamshiri AR, Zahraei SM, Baxter L, Shakerian S, Chaudhri I, Fleming JA, Munier A, Baradaran HR.

Vaccine. 2015 May 7;33 Suppl 1:A192-200. doi: 10.1016/j.vaccine.2014.12.035.

PMID:
25919160
23.

Timing and delay in children vaccination; evaluation of expanded program of immunization in outskirt of Iranian cities.

Rejali M, Mohammadbeigi A, Mokhtari M, Zahraei SM, Eshrati B.

J Res Health Sci. 2015 Winter;15(1):54-8.

24.

The First Macrolide-Resistant Bordetella pertussis Strains Isolated From Iranian Patients.

Shahcheraghi F, Nakhost Lotfi M, Nikbin VS, Shooraj F, Azizian R, Parzadeh M, Allahyar Torkaman MR, Zahraei SM.

Jundishapur J Microbiol. 2014 Jun;7(6):e10880. doi: 10.5812/jjm.10880. Epub 2014 Jun 1.

25.

Is there still an immunity gap in high-level national immunization coverage, Iran?

Zahraei SM, Eshrati B, Gouya MM, Mohammadbeigi A, Kamran A.

Arch Iran Med. 2014 Oct;17(10):698-701. doi: 0141710/AIM.0011.

26.

Syringe-type and needle gauge have no role in adverse events following DTwP immunization: a randomized multicenter trial.

Fateh M, Emamian MH, Zahraei SM, Fotouhi A.

Pediatr Infect Dis J. 2014 Sep;33(9):e239-46. doi: 10.1097/INF.0000000000000374.

PMID:
24906043
27.

Implementation of a national measles elimination program in Iran: Phylogenetic analysis of measles virus strains isolated during 2010-2012 outbreaks.

Salimi V, Abbasi S, Zahraei SM, Fatemi-Nasab G, Adjaminezhad-Fard F, Shadab A, Ghavami N, Zareh-Khoshchehre R, Soltanshahi R, Bont L, Mokhtari-Azad T.

PLoS One. 2014 Apr 15;9(4):e94846. doi: 10.1371/journal.pone.0094846. eCollection 2014.

28.

Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran.

Habibian S, Mehrabi-Tavana A, Ahmadi Z, Izadi M, Jonaidi N, Darakhshanpoure J, Salesi M, Zahraei SM, Ataee RA.

Iran Red Crescent Med J. 2013 Oct;15(10):e8053. doi: 10.5812/ircmj.8053. Epub 2013 Oct 5.

29.

Epidemiology of four main nosocomial infections in Iran during March 2007 - March 2008 based on the findings of a routine surveillance system.

Zahraei SM, Eshrati B, Masoumi Asl H, Pezeshki Z.

Arch Iran Med. 2012 Dec;15(12):764-6. doi: 0121512/AIM.009.

30.

The use of oral fluid samples spotted on filter paper for the detection of measles virus using nested rt-PCR.

Sheikhakbari S, Mokhtari-Azad T, Salimi V, Norouzbabaei Z, Abbasi S, Zahraei SM, Shahmahmoodi S.

J Clin Lab Anal. 2012 May;26(3):215-22. doi: 10.1002/jcla.21496.

PMID:
22628239
31.

Successful control and impending elimination of measles in the Islamic Republic of Iran.

Zahraei SM, Gouya MM, Azad TM, Soltanshahi R, Sabouri A, Naouri B, Alexander JP Jr.

J Infect Dis. 2011 Jul;204 Suppl 1:S305-11. doi: 10.1093/infdis/jir076.

PMID:
21666178
32.

Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008.

Shahmahmoodi S, Mamishi S, Aghamohammadi A, Aghazadeh N, Tabatabaie H, Gooya MM, Zahraei SM, Mousavi T, Yousefi M, Farrokhi K, Mohammadpour M, Ashrafi MR, Nategh R, Parvaneh N.

Emerg Infect Dis. 2010 Jul;16(7):1133-6. doi: 10.3201/eid1607.091606.

33.

Role of National Immunization Technical Advisory Group on improvement of immunization programmes in the Islamic Republic of Iran.

Zahraei SM, Marandi A, Sadrizadeh B, Gouya MM, Rezaei P, Vazirian P, Yaghini F.

Vaccine. 2010 Apr 19;28 Suppl 1:A35-8. doi: 10.1016/j.vaccine.2010.02.030.

PMID:
20412994
34.

Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study.

Mousavi SM, Hamkar R, Gouya MM, Safaie A, Zahraei SM, Yazdani Z, Asbaghi Namini S, Bertagnolio S, Sutherland D, Sandstrom P, Brooks J.

Arch Virol. 2010 Mar;155(3):329-34. doi: 10.1007/s00705-009-0583-6. Epub 2010 Jan 6.

PMID:
20052598
35.

Distribution of class I integron and sulfamethoxazole trimethoprim constin in Vibrio cholerae isolated from patients in Iran.

Adabi M, Bakhshi B, Goudarzi H, Zahraei SM, Pourshafie MR.

Microb Drug Resist. 2009 Sep;15(3):179-84. doi: 10.1089/mdr.2009.0885.

PMID:
19728775
36.

Comparison of distribution of virulence determinants in clinical and environmental isolates of Vibrio cholera.

Bakhshi B, Pourshafie MR, Navabakbar F, Tavakoli A, Shahcheraghi F, Salehi M, Faradjzadegan Z, Zahraei SM.

Iran Biomed J. 2008 Jul;12(3):159-65.

37.

Progress in measles and rubella elimination in Iran.

Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.

Pediatr Infect Dis J. 2007 Dec;26(12):1137-41.

PMID:
18043452

Supplemental Content

Loading ...
Support Center